candesartan has been researched along with Brain Inflammation in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torika, N | 1 |
| Asraf, K | 1 |
| Apte, RN | 1 |
| Fleisher-Berkovich, S | 1 |
| Rodriguez-Perez, AI | 1 |
| Sucunza, D | 1 |
| Pedrosa, MA | 1 |
| Garrido-Gil, P | 1 |
| Kulisevsky, J | 1 |
| Lanciego, JL | 1 |
| Labandeira-Garcia, JL | 1 |
2 other studies available for candesartan and Brain Inflammation
| Article | Year |
|---|---|
Candesartan ameliorates brain inflammation associated with Alzheimer's disease.
Topics: Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-S | 2018 |
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.
Topics: alpha-Synuclein; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compound | 2018 |